HIF-1α and HIF-2α regulate a number of physiological pathways involved in cancer, such as cell proliferation, survival, apoptosis, angiogenesis, glucose metabolism, immune cell activation and stem cells [59,60,61]. This evidence concerns the gene HIF1A and cancer.